AgomAb Therapeutics NV American Depositary Shares
AGMBNASDAQHEALTHCARE
About AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases with a focus on chronic fibrotic indications with unmet medical needs. The company is headquartered in Antwerp, Belgium.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- USA
- Fiscal year end
- December
- Website
- agomab.com
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.